(Q45982388)

18 December 2017

title

Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis. (English)

1 reference

18 December 2017

main subject

visceral leishmaniasis

1 reference

Débora M Santana

1

1 reference

18 December 2017

Gulnara P Borja-Cabrera

2

1 reference

18 December 2017

Edilma Paraguai de Souza

3

1 reference

18 December 2017

Nancy R Sturm

4

1 reference

18 December 2017

Clarisa B Palatnik de Sousa

5

1 reference

18 December 2017

David A Campbell

6

1 reference

18 December 2017

publication date

1 April 2002

1 reference

18 December 2017

Molecular and Biochemical Parasitology

published in

1 reference

18 December 2017

volume

120

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

315-319

1 reference

18 December 2017

The subclinical form of experimental visceral leishmaniasis in dogs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutical and epidemiological findings (1977-1983)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

rK39: A Cloned Antigen of Leishmania chagasi that Predicts Active Visceral Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Serodiagnosis of canine visceral leishmaniasis in Portugal: comparison of three methods

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Nucleoside hydrolase from Leishmania major. Cloning, expression, catalytic properties, transition state inhibitors, and the 2.5-å crystal structure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-6851%2802%2900010-5

7 January 2021

10.1016/S0166-6851(02)00010-5

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017